Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | ALB | P02768 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | TK1 | P04183 | 7/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8920703 | 1.00 | LMNA (0.58) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL13286394 | 1.00 | LMNA (0.58) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL27505365 | 1.00 | LMNA (0.58) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL14596607 | 1.00 | LMNA (0.58) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL925743 | 1.00 | LMNA (0.58) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL29711774 | 1.00 | LMNA (0.58) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL14421795 | 1.00 | LMNA (0.58) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL762579 | 1.00 | LMNA (0.58) | LMNAALBBLMALDH1A1POLB | |
| SCHEMBL22992337 | 1.00 | LMNA (0.58) | LMNAALBBLMALDH1A1POLB | |
| Methane SCHEMBL25262791 | 0.99 | TK1 (0.57) | LMNAALBBLMALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 33228 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146286-A1 | SMALL RNA-BASED PROGNOSTIC SIGNATURES AND THERAPEUTIC COMPOSITIONS FOR IDIOPATHIC PULMONARY FIBROSIS | GATEHOUSE BIO INC. (US) | 2026-05-28 | — | — | US | claimed |
| CN-122094697-A | Aptamer conjugates for targeted degradation of osteopetron | — | 2026-05-26 | — | — | CN | claimed |
| CN-122081333-A | Theophylline aptamer and virtual screening method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122071706-A | Agents and methods for silencing HIF2A | 杭州迪纳元昇生物科技有限公司 | 2026-05-22 | — | — | CN | claimed |
| WO-2026103905-A1 | DSRNA MOLECULE FOR REGULATING ALK7 EXPRESSION | 大睿生物医药科技(上海)有限公司 | 2026-05-21 | — | — | WO | claimed |
| EP-4745238-A1 | OLIGONUCLEOTIDE TARGETING ANGIOTENSINOGEN AND USE THEREOF | Anlong Biopharmaceutical Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| CN-122060746-A | Nucleic acid aptamer targeting iron regulatory protein IRPs and application thereof | 西北农林科技大学 | 2026-05-19 | — | — | CN | claimed |
| WO-2026102302-A1 | POLYNUCLEOTIDES CONTAINING A MODIFIED 3'-REGION | MODERNATX, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260132456-A1 | Methods for Extraction and Sequencing of Nucleic Acid | EARLHAM ENTPR LTD (GB) | 2026-05-14 | — | — | US | claimed |
| US-20260125681-A1 | DOUBLE-STRANDED RNAi AGENTS FOR TARGETING AND REGULATING HBV GENE EXPRESSION, AND A USE THEREOF | HANGZHOU TIANLONG PHARMACEUTICAL CO., LTD. (CN) | 2026-05-07 | — | — | US | claimed |
| WO-1989009778-A1 | OLIGONUCLEOTIDE CONTAINING 6-THIOGUANINE AT A PREDETERMINED SITE | CHEMICAL INDUSTRY INSTITUTE OF TOXICOLOGY (US) | 1989-10-19 | — | — | WO | claimed |
| EP-0337599-A1 | Compounds and pharmaceutical preparations useful in reduction of the severity of 3'-azido-3'-deoxythymidine-induced anaemia | ERBAMONT, INC. (US) | 1989-10-18 | — | — | EP | claimed |
| CN-1034134-A | Be used for the treatment of compositions and preparation method that back virus merges cancer | UNIV LIVERPOOL (GB) | 1989-07-26 | — | — | CN | claimed |
| EP-0306597-A2 | Antiviral nucleosides | THE WELLCOME FOUNDATION LIMITED (GB) | 1989-03-15 | — | — | EP | claimed |
| US-4786724-A | INTERMEDIATES FOR SOLID PHASE SYNTHESIS | NORTHWESTERN UNIVERSITY (US) | 1988-11-22 | — | — | US | claimed |
| CN-87105612-A | PYRIMIDINE DERIVATIVES | — | 1988-03-16 | — | — | CN | claimed |
| CN-87105758-A | Pyrimidine derivatives, their production and use | — | 1988-03-02 | — | — | CN | claimed |
| EP-0243153-A2 | Human G-CSF protein expression | IMMUNEX CORPORATION (US) | 1987-10-28 | — | — | EP | claimed |
| EP-0180225-A2 | Plasmid to increase the production of penicillin-G amidase | Roche Diagnostics GmbH (DE) | 1986-05-07 | — | — | EP | claimed |
| EP-0113452-A2 | Magnetic particles as supports for organic synthesis | GENETICS INSTITUTE, INC. (US) | 1984-07-18 | — | — | EP | claimed |